AmpliPhi Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- AmpliPhi Biosciences's estimated annual revenue is currently $4M per year.
- AmpliPhi Biosciences's estimated revenue per employee is $155,000
Employee Data
- AmpliPhi Biosciences has 26 Employees.
- AmpliPhi Biosciences grew their employee count by 0% last year.
AmpliPhi Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Chemistry,Manufacturing & Control | Reveal Email/Phone |
AmpliPhi Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is AmpliPhi Biosciences?
In March 2011 Targeted Genetics Corporation announced the change of the Company's name to AmpliPhi Biosciences Corporation to reflect its positioning as an innovative biotechnology company focused on the advancement of new generation anti-bacterial therapeutics.
keywords:N/A
N/A
Total Funding
26
Number of Employees
$4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
AmpliPhi Biosciences News
... Analysis 2028 | Top Players as Alnylam Pharmaceuticals Inc., GlaxoSmithKline, Prana Biotechnology Limited, AmpliPhi Biosciences Corp.
... LegoChem Biosciences Inc, Inhibrx LP, ContraFect Corp, AmpliPhi Biosciences Corp, Melinta Therapeutics Inc, Shionogi & Co Ltd.
... Insights 2022 2028 | Alnylam Pharmaceuticals Inc., GlaxoSmithKline, Prana Biotechnology Limited, AmpliPhi Biosciences Corp.
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.7M | 26 | 0% | $122.8M |
#2 | $2.6M | 26 | N/A | N/A |
#3 | $2.6M | 26 | N/A | N/A |
#4 | $2.6M | 26 | N/A | N/A |
#5 | $2.6M | 26 | N/A | N/A |